Teladoc Health Q3 Earnings: Revenue Beat, EPS Beat, Shares Jump 10%
Portfolio Pulse from Adam Eckert
Teladoc Health reported Q3 earnings that exceeded analyst expectations, with revenue of $640.51 million and a smaller-than-expected EPS loss. Despite a 3% year-over-year revenue decline, shares rose 10% in after-hours trading. The company anticipates modest growth in its Integrated Care segment for Q4 and 2024.
October 30, 2024 | 10:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Teladoc Health's Q3 earnings exceeded expectations, with revenue of $640.51 million and a smaller-than-expected EPS loss. Despite a 3% year-over-year revenue decline, shares rose 10% in after-hours trading. The company anticipates modest growth in its Integrated Care segment for Q4 and 2024.
Teladoc Health's better-than-expected Q3 results, including a revenue beat and a smaller EPS loss, have positively impacted investor sentiment, leading to a 10% increase in share price. The company's guidance for modest growth in its Integrated Care segment further supports a positive outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100